Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

• Egile Nagusiak: Mahlich J (Egilea), Nishi M (Egilea), Saito Y (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2015-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Jörg Mahlich,1,2 Masamichi Nishi,3 Yoshimichi Saito11Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan; 2Düsseldorf Institute for Competition Economics, University of Düsseldorf, Düsseldorf, Germany; 3Pricing, Janssen Pharmaceutical KK, Tokyo, JapanBackgro...